<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Large for gestational age (LGA) newborn
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Large for gestational age (LGA) newborn
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Large for gestational age (LGA) newborn
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Author:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            George T Mandy, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Steven A Abrams, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Carrie Armsby, MD, MPH
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 29, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants who are born large for gestational age (LGA), especially full-term or post-term infants, are at risk for perinatal morbidity and potentially long-term metabolic complications.
        </p>
        <p>
         The definition, prevalence, risk factors, complications, evaluation, and management of infants born LGA will be reviewed here. Other related topics include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/5058.html" rel="external">
          "Infants of mothers with diabetes (IMD)"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4443.html" rel="external">
          "Fetal macrosomia"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         (See
         <a class="medical medical_review" href="/z/d/html/4972.html" rel="external">
          "Postterm infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H339470">
         <span class="h1">
          DEFINITIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          LGA
         </strong>
         – LGA is generally defined as a birth weight (BW) &gt;90
         <sup>
          th
         </sup>
         percentile for gestational age (GA)  (
         <a class="graphic graphic_figure graphicRef121969" href="/z/d/graphic/121969.html" rel="external">
          figure 1
         </a>
         ). However, it has been suggested that the definition be restricted to infants with BW ≥97
         <sup>
          th
         </sup>
         percentile (2 standard deviations above the mean), since infants in this category are at greatest risk for perinatal morbidity and mortality [
         <a href="#rid1">
          1,2
         </a>
         ]. Using normative data based upon all singleton live births in the United States in 2017, the 90
         <sup>
          th
         </sup>
         percentile for BW among infants born at 40 weeks gestation corresponds to approximately 4000 g, and the 97
         <sup>
          th
         </sup>
         percentile corresponds to approximately 4400 g [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Macrosomia
         </strong>
         – Macrosomia is a related term that refers to excessive intrauterine growth based upon an absolute BW threshold, regardless of GA. Macrosomia is usually defined as BW &gt;4000 or &gt;4500 g. The American College of Obstetricians and Gynecologists (ACOG) uses the 4500 g threshold because morbidity increases sharply beyond this BW.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         A grading system for macrosomia has been proposed based on BW (see
         <a class="medical medical_review" href="/z/d/html/4443.html" rel="external">
          "Fetal macrosomia", section on 'Definition'
         </a>
         ):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Grade 1 – 4000 to 4499 g
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Grade 2 – 4500 to 4999 g
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Grade 3 – &gt;5000 g
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Appropriate for gestational age (AGA)
         </strong>
         – AGA is defined as BW between the 10
         <sup>
          th
         </sup>
         and 90
         <sup>
          th
         </sup>
         percentile for GA  (
         <a class="graphic graphic_figure graphicRef121969" href="/z/d/graphic/121969.html" rel="external">
          figure 1
         </a>
         ). For term infants, this corresponds to BW between approximately 2500 and 4000 g.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Small for gestational age (SGA)
         </strong>
         – SGA is typically defined as BW &lt;10th percentile for GA  (
         <a class="graphic graphic_figure graphicRef121969" href="/z/d/graphic/121969.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="medical medical_review" href="/z/d/html/5062.html" rel="external">
          "Infants with fetal (intrauterine) growth restriction", section on 'Small for gestational age'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H68825427">
         <span class="h1">
          PREVALENCE
         </span>
         <span class="headingEndMark">
          —
         </span>
         The prevalence of LGA varies depending on the definition used. When defining LGA as birth weight (BW) &gt;90
         <sup>
          th
         </sup>
         percentile for gestational age (GA), approximately 10 percent of newborns will be classified as LGA. When using the BW &gt;97
         <sup>
          th
         </sup>
         percentile definition, approximately 3 percent of newborns will be classified as LGA.
        </p>
        <p>
         The prevalence of macrosomia also varies depending on the definition. Approximately 7 percent of all live births in the United States have BW ≥4000 g and approximately 1 percent have BW ≥4500 g [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h1">
          RISK FACTORS AND ETIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Although the mechanisms that control fetal weight gain and growth are poorly understood, excessive fetal growth appears to be due to increased delivery of nutrients to the fetus, which is influenced/caused by genetic factors and intrauterine environmental factors, or a combination of the two.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Genetic factors
         </strong>
         – Macrosomia is a characteristic feature of certain genetic syndromes (eg, Beckwith-Wiedemann syndrome). In addition, mothers who were born LGA are more likely to deliver LGA infants compared with those who were appropriate for gestational age. (See
         <a class="local">
          'Genetic factors'
         </a>
         below.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         Limited data suggest that placental epigenetic alterations may contribute to increased fetal growth [
         <a href="#rid5">
          5-8
         </a>
         ].
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Antenatal maternal factors
         </strong>
         – These include (see
         <a class="local">
          'Maternal factors'
         </a>
         below):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Maternal diabetes (pregestational or gestational) (see
         <a class="local">
          'Maternal diabetes'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Maternal obesity (see
         <a class="local">
          'Maternal prepregnancy weight'
         </a>
         below)
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Excessive gestational weight gain (see
         <a class="local">
          'Excessive maternal weight gain'
         </a>
         below)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H68825740">
         <span class="h2">
          Genetic factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Certain genetic disorders are characterized by early excessive growth resulting in macrosomia/LGA. Some examples include  (
         <a class="graphic graphic_table graphicRef62116" href="/z/d/graphic/62116.html" rel="external">
          table 1
         </a>
         ):
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beckwith-Wiedemann syndrome (see
         <a class="medical medical_review" href="/z/d/html/13555.html" rel="external">
          "Beckwith-Wiedemann syndrome"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Simpson-Golabi-Behmel syndrome (OMIM #
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F312870&amp;token=tEpDslnpc0F0kICl%2Fz7sFQyHoPb7eaMS7PXQVX%2BrKdxyKGlnMaYcqz7sEewKVs4k&amp;TOPIC_ID=5059" target="_blank">
          312870
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Sotos syndrome (see
         <a class="medical medical_review" href="/z/d/html/16660.html" rel="external">
          "Microdeletion syndromes (chromosomes 1 to 11)", section on '5q35 deletion syndrome (Sotos syndrome)'
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Weaver syndrome (OMIM #
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F277590&amp;token=tEpDslnpc0F0kICl%2Fz7sFWdn73fzwsrnK0ZHvwqS9sZ94Vxc8LW%2Foq6HOdAnE04Q&amp;TOPIC_ID=5059" target="_blank">
          277590
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Berardinelli lipodystrophy (see
         <a class="medical medical_review" href="/z/d/html/1788.html" rel="external">
          "Lipodystrophic syndromes", section on 'Congenital generalized lipodystrophy'
         </a>
         )
        </p>
        <p>
        </p>
        <p>
         In addition, macrosomia/LGA is more common in newborns whose mother and/or older sibling(s) were born LGA.
        </p>
        <p class="headingAnchor" id="H68825770">
         <span class="h2">
          Race and ethnicity
         </span>
         <span class="headingEndMark">
          —
         </span>
         Birth weight (BW) is influenced by race and ethnicity. In a report from the United States that included all singleton live births in 2017, macrosomia (BW ≥4000 g) was more common among White newborns compared with Black or Hispanic newborns (9.1 versus 4.1 and 6.7 percent, respectively) [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H68825693">
         <span class="h2">
          Maternal factors
         </span>
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h3">
          Maternal diabetes
         </span>
         <span class="headingEndMark">
          —
         </span>
         Macrosomia is common in infants of mothers with diabetes (IMD), especially when maternal diabetes is poorly controlled. Excessive delivery of nutrients to the fetus results in fetal hyperglycemia, hyperinsulinemia, and increased growth. In IMDs, macrosomia is also associated with disproportionate growth with an increased ponderal index that results in higher chest-to-head and shoulder-to-head ratios, higher body fat, and thicker upper extremity skinfolds compared with LGA offspring of nondiabetic mothers  (
         <a class="graphic graphic_picture graphicRef54212" href="/z/d/graphic/54212.html" rel="external">
          picture 1
         </a>
         ). This disproportionate macrosomia increases the risk of birth injuries, especially shoulder dystocia. (See
         <a class="medical medical_review" href="/z/d/html/5058.html" rel="external">
          "Infants of mothers with diabetes (IMD)", section on 'Macrosomia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/94859.html" rel="external">
          "Pregestational (preexisting) diabetes: Preconception counseling, evaluation, and management"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h3">
          Maternal prepregnancy weight
         </span>
         <span class="headingEndMark">
          —
         </span>
         The risk of an LGA offspring increases in a linear fashion as the prepregnancy maternal weight rises. As a result, the highest risk of delivering an LGA infant occurs in obese mothers. This relationship is independent of the increased prevalence of gestational diabetes in obese women. The evidence for the effect of maternal prepregnancy weight on BW is presented separately. (See
         <a class="medical medical_review" href="/z/d/html/433.html" rel="external">
          "Obesity in pregnancy: Complications and maternal management", section on 'Large for gestational age'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h3">
          Excessive maternal weight gain
         </span>
         <span class="headingEndMark">
          —
         </span>
         Excessive maternal weight gain during pregnancy is associated with macrosomia. Women with normal prepregnancy body mass index who gained more than 35 lbs (15.9 kg) had an almost 2.5 times greater risk of delivering an LGA infant compared with mothers who gained between 25 and 35 lbs (11.3 and 15.9 kg) [
         <a href="#rid9">
          9
         </a>
         ]. The amount of weight gain associated with an LGA birth is lower in women who are overweight or obese, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/433.html" rel="external">
          "Obesity in pregnancy: Complications and maternal management", section on 'Large for gestational age'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/441.html" rel="external">
          "Gestational weight gain", section on 'Recommendations for gestational weight gain'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/441.html" rel="external">
          "Gestational weight gain", section on 'Overweight and obese pregnant people'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h3">
          Other factors
         </span>
         <span class="headingEndMark">
          —
         </span>
         Other factors associated with increased risk of macrosomia/LGA include:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Multiparity
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Advanced maternal age
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Post-term pregnancy (see
         <a class="medical medical_review" href="/z/d/html/4972.html" rel="external">
          "Postterm infant", section on 'Macrosomia'
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H13">
         <span class="h1">
          COMPLICATIONS
         </span>
        </p>
        <p class="headingAnchor" id="H4179755584">
         <span class="h2">
          Term LGA infants
         </span>
         <span class="headingEndMark">
          —
         </span>
         Term newborns with macrosomia/LGA are at increased risk for neonatal complications and mortality compared with appropriate for gestational age (AGA) infants [
         <a href="#rid2">
          2,10
         </a>
         ]. The risk of morbidity increases sharply as the BW increases above 4500 g.
        </p>
        <p>
         Macrosomia is also associated with increased risk of peripartum maternal complications, including cesarean delivery, severe postpartum hemorrhage, and vaginal lacerations. These risks are discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/4443.html" rel="external">
          "Fetal macrosomia"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5397.html" rel="external">
          "Shoulder dystocia: Intrapartum diagnosis, management, and outcome", section on 'Maternal'
         </a>
         .)
        </p>
        <p>
         The increased morbidity seen in LGA infants results in a higher utilization of neonatal intensive care unit (NICU) resources compared with AGA newborns [
         <a href="#rid11">
          11
         </a>
         ]. The most common diagnoses seen in LGA infants, which account for approximately half of NICU admissions in this population, include respiratory distress (particularly transient tachypnea of the newborn [TTN]), hypoglycemia, and meconium aspiration [
         <a href="#rid11">
          11
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H1868478455">
         <span class="h3">
          Mortality
         </span>
         <span class="headingEndMark">
          —
         </span>
         Infants who are born extremely LGA (ie, birth weight [BW] &gt;97
         <sup>
          th
         </sup>
         percentile) or with severe macrosomia (ie, BW &gt;5000 g) have a more than twofold increased risk of neonatal mortality compared with AGA infants (adjusted odds ratio [aOR] 2.69, 95% CI 1.91-3.8) [
         <a href="#rid2">
          2,12
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H14">
         <span class="h3">
          Birth injury
         </span>
         <span class="headingEndMark">
          —
         </span>
         Macrosomia predisposes to shoulder dystocia and birth injury, including brachial plexus injury and clavicular fracture [
         <a href="#rid2">
          2,13,14
         </a>
         ]. The risk of birth injury depends upon the severity of macrosomia (the risk is highest among newborns &gt;4500 g) and route of delivery (risk is greater in vaginal compared with cesarean delivery) [
         <a href="#rid13">
          13
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5031.html" rel="external">
          "Neonatal birth injuries"
         </a>
         .)
        </p>
        <p>
         The neonatal complications of shoulder dystocia are discussed in greater detail separately. (See
         <a class="medical medical_review" href="/z/d/html/5397.html" rel="external">
          "Shoulder dystocia: Intrapartum diagnosis, management, and outcome", section on 'Infant'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1061762709">
         <span class="h3">
          Perinatal asphyxia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Macrosomic infants, especially infants of mothers with diabetes (IMD), are at increased risk for perinatal asphyxia. Several studies have reported that LGA infants more commonly have low five-minute Apgar scores compared with AGA infants [
         <a href="#rid1">
          1,2,12,13
         </a>
         ]. Contributing factors are thought to be increased intrauterine oxygen utilization due to fetal hyperglycemia and hyperinsulinemia, especially in IMDs, and complications of delivery related to shoulder dystocia. (See
         <a class="medical medical_review" href="/z/d/html/5058.html" rel="external">
          "Infants of mothers with diabetes (IMD)", section on 'Perinatal asphyxia'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5397.html" rel="external">
          "Shoulder dystocia: Intrapartum diagnosis, management, and outcome", section on 'Infant'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1891580">
         <span class="h3">
          Respiratory distress
         </span>
         <span class="headingEndMark">
          —
         </span>
         LGA infants are more likely to develop respiratory distress than AGA infants [
         <a href="#rid2">
          2,11
         </a>
         ]. Respiratory distress in this population may be due to:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         TTN, likely related to the increased incidence of cesarean delivery in LGA infants. (See
         <a class="medical medical_review" href="/z/d/html/5066.html" rel="external">
          "Transient tachypnea of the newborn"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Meconium aspiration. (See
         <a class="medical medical_review" href="/z/d/html/4971.html" rel="external">
          "Meconium aspiration syndrome: Pathophysiology, clinical manifestations, and diagnosis"
         </a>
         .)
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Preterm birth and associated risk of respiratory distress syndrome (RDS). Preterm birth is more likely in IMDs. (See
         <a class="medical medical_review" href="/z/d/html/5055.html" rel="external">
          "Respiratory distress syndrome (RDS) in the newborn: Clinical features and diagnosis"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H18">
         <span class="h3">
          Hypoglycemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         LGA infants can develop hypoglycemia when the placental supply of glucose is interrupted at birth. In two large European studies, reported rates of hypoglycemia among LGA newborns ranged from 16 to 19 percent [
         <a href="#rid15">
          15,16
         </a>
         ]. Hypoglycemia can occur in LGA newborns born to mothers with or without diabetes. In one study, hypoglycemia occurred in 15 percent of LGA newborns born to mothers without diabetes [
         <a href="#rid15">
          15
         </a>
         ]. (See
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H19">
         <span class="h3">
          Polycythemia
         </span>
         <span class="headingEndMark">
          —
         </span>
         Polycythemia is a common complication seen in LGA newborns born to mothers with or without diabetes [
         <a href="#rid17">
          17
         </a>
         ]. The mechanism of polycythemia is thought to be due to an increased production of erythropoietin, which results from fetal hypoxia caused by the increased oxidative demands associated with hyperglycemia and hyperinsulinemia. (See
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H22">
         <span class="h3">
          Congenital anomalies
         </span>
         <span class="headingEndMark">
          —
         </span>
         Minor congenital anomalies are more common in LGA than AGA infants. This was evaluated in a retrospective case-control study of more than two million births in Latin America [
         <a href="#rid18">
          18
         </a>
         ]. Of the nearly 32,000 infants with congenital anomalies, 5 percent were LGA [
         <a href="#rid18">
          18
         </a>
         ]. The most common abnormalities associated with macrosomia included:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Talipes calcaneovalgus (see
         <a class="medical medical_review" href="/z/d/html/5030.html" rel="external">
          "Lower extremity positional deformations"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hip subluxation (see
         <a class="medical medical_review" href="/z/d/html/6288.html" rel="external">
          "Developmental dysplasia of the hip: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Hydrocephalus (see
         <a class="medical medical_review" href="/z/d/html/110031.html" rel="external">
          "Hydrocephalus in children: Clinical features and diagnosis"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H4236705526">
         <span class="h3">
          Hospital readmissions
         </span>
         <span class="headingEndMark">
          —
         </span>
         Compared with AGA infants, LGA infants are more likely to be readmitted to the hospital within the first month after discharge from the birth hospitalization. In a population-based study from France that included data on &gt;65,000 term singleton births, 28-day readmission rates were higher for LGA compared with AGA infants (4.3 versus 3.5 percent, respectively; adjusted odds ratio 1.21, 95% CI 1.06-1.39) [
         <a href="#rid19">
          19
         </a>
         ]. The most common reasons for readmission were infections (58 percent), feeding and digestive disorders (22 percent), and jaundice or other metabolic disorder (5 percent).
        </p>
        <p class="headingAnchor" id="H3108146493">
         <span class="h3">
          Potential long-term effects
         </span>
         <span class="headingEndMark">
          —
         </span>
         Individuals who were born LGA, whether born to a mother with or without diabetes, may have long-term metabolic effects that increase the risk of obesity and insulin resistance in adulthood [
         <a href="#rid20">
          20-25
         </a>
         ]. The impact on cardiovascular health is less clear, but there appears to be an increased risk of cardiovascular disease (CVD) among individuals born LGA [
         <a href="#rid26">
          26
         </a>
         ]. Studies have generally found that the relationship between BW and adult CVD is U-shaped, with increased risk at both extremes (ie, BW &lt;2500 g and &gt;4000 g) [
         <a href="#rid26">
          26
         </a>
         ]. The type of CVD appears to vary between individuals with low versus high BW; low BW is linked to greater risk of coronary heart disease, whereas high BW may be associated with increased risk of arterial fibrillation and stroke.
        </p>
        <p>
         Macrosomia/LGA does not appear to be an independent predictor of long-term neurodevelopmental impairment (NDI) as outcomes appear to be generally similar for LGA and AGA infants [
         <a href="#rid27">
          27-29
         </a>
         ]. However, LGA infants who were exposed to poorly controlled diabetes during pregnancy may be at risk for NDI, as discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5058.html" rel="external">
          "Infants of mothers with diabetes (IMD)", section on 'Neurodevelopmental outcome'
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H1940874647">
         <span class="h2">
          Preterm LGA infants
         </span>
         <span class="headingEndMark">
          —
         </span>
         It is unclear whether preterm infants who are LGA have a higher or lower risk of mortality and morbidity compared with AGA infants with the same gestational age (GA). Some studies suggest that higher BW may be a protective factor for preterm neonates [
         <a href="#rid30">
          30,31
         </a>
         ], others studies suggest that preterm LGA infants may be at higher risk for mortality [
         <a href="#rid27">
          27
         </a>
         ], and some studies have concluded that being LGA does not impact risk of morbidity and mortality in preterm neonates [
         <a href="#rid32">
          32
         </a>
         ].
        </p>
        <p>
         In a study from the Vermont Oxford Network of &gt;150,000 preterm infants (GA 22 to 29 weeks), LGA preterm infants compared with AGA preterm infants had lower mortality and reduced rates of respiratory distress syndrome, patent ductus arteriosus (PDA), necrotizing enterocolitis (NEC), late-onset sepsis, severe retinopathy of prematurity (ROP), and bronchopulmonary dysplasia (BPD). Rates of early-onset sepsis and severe intraventricular hemorrhage were slightly higher in LGA infants, though these findings were not consistent across the GA range.
        </p>
        <p>
         By contrast, a retrospective cohort study of preterm infants (GA &lt;29 weeks) from the Canadian Neonatal Network and Canadian Neonatal Follow-Up Network databases, in-hospital mortality was higher for LGA infants compared with AGA infants (25 versus 18 percent) [
         <a href="#rid27">
          27
         </a>
         ]. This study did not detect any differences in rates of neonatal morbidities (eg, PDA requiring treatment, NEC, BPD, ROP, severe IVH, late-onset sepsis) between LGA and AGA infants.
        </p>
        <p class="headingAnchor" id="H1891711">
         <span class="h1">
          EVALUATION AND MANAGEMENT OF THE LGA NEWBORN
         </span>
         <span class="headingEndMark">
          —
         </span>
         Management of LGA newborns includes screening for and treating complications associated with macrosomia (eg, hypoglycemia, respiratory distress); evaluating for the underlying etiology of increased growth, if not readily apparent from the history and physical examination; and providing routine newborn care.
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Prior to delivery, an assessment of the need for neonatal resuscitation is made based on the gestational age, estimated birth weight, maternal history (including complications during pregnancy), prenatally diagnosed congenital abnormalities, and mode of delivery (cesarean versus vaginal). (See
         <a class="medical medical_review" href="/z/d/html/5015.html" rel="external">
          "Neonatal resuscitation in the delivery room", section on 'Anticipation of resuscitation need'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Immediately after delivery, routine neonatal care is provided that includes drying, clearing the airway of secretions, maintaining warmth, and a rapid clinical assessment. If the infant does not require additional resuscitation, the infant should be given to the mother for skin-to-skin care and initiation of breastfeeding in the delivery room. LGA infants should be fed as quickly as possible after delivery to avoid hypoglycemia. (See
         <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">
          "Overview of the routine management of the healthy newborn infant", section on 'Assessment and disposition'
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/101425.html" rel="external">
          "Management and outcome of neonatal hypoglycemia", section on 'Oral feeds'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Further evaluation following transition from the delivery room includes a comprehensive clinical assessment to identify any abnormalities that might suggest an underlying genetic syndrome  (
         <a class="graphic graphic_table graphicRef62116" href="/z/d/graphic/62116.html" rel="external">
          table 1
         </a>
         ) or evidence of birth trauma (eg, brachial plexus injury or clavicular fracture). (See
         <a class="local">
          'Genetic factors'
         </a>
         above and
         <a class="local">
          'Birth injury'
         </a>
         above and
         <a class="local">
          'Congenital anomalies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         All LGA infants should undergo screening for hypoglycemia within the first hours following birth, as described separately. (See
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia", section on 'Screening'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If the newborn has any signs or symptoms that may be due to polycythemia (eg, cyanosis, tachypnea, poor feeding), the hematocrit should be measured. (See
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         If there are no significant complications that require further intervention, routine newborn care should be provided. (See
         <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">
          "Overview of the routine management of the healthy newborn infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1892632">
         <span class="h1">
          SUMMARY AND RECOMMENDATIONS
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Definitions
         </strong>
         – Large for gestational age (LGA) is generally defined as a birth weight (BW) &gt;90
         <sup>
          th
         </sup>
         percentile  (
         <a class="graphic graphic_figure graphicRef121969" href="/z/d/graphic/121969.html" rel="external">
          figure 1
         </a>
         ). A higher threshold (BW ≥97
         <sup>
          th
         </sup>
         percentile) has been proposed since infants in this category are at greatest risk for perinatal morbidity and mortality. Macrosomia is a related term that refers to excessive intrauterine growth based upon an absolute BW threshold, regardless of GA. Macrosomia is usually defined as BW &gt;4000 or &gt;4500 g. The risk of morbidity increases sharply if the BW exceeds 4500 g. (See
         <a class="local">
          'Definitions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Prevalence
         </strong>
         – The prevalence of LGA/macrosomia varies depending on the definition used. When defining LGA as BW &gt;90
         <sup>
          th
         </sup>
         percentile for GA, approximately 10 percent of newborns will be classified as LGA. When using the &gt;97
         <sup>
          th
         </sup>
         percentile definition, approximately 3 percent of newborns will be classified as LGA. In the United States, approximately 7 percent of all live births have BW ≥4000 g and approximately 1 percent have BW ≥4500 g. (See
         <a class="local">
          'Prevalence'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Risk factors and etiology
         </strong>
         – Macrosomia/LGA is associated with genetic factors (eg, syndromes such as Beckwith-Wiedemann  (
         <a class="graphic graphic_table graphicRef62116" href="/z/d/graphic/62116.html" rel="external">
          table 1
         </a>
         )), prenatal maternal factors (eg, maternal diabetes, obesity, excessive maternal weight gain), and other maternal factors, such as advanced maternal age and multiparity. (See
         <a class="local">
          'Risk factors and etiology'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Complications
         </strong>
         – Infants who are LGA compared with those who are born appropriate for gestational age (AGA) are at increased risk for short- and long-term complications, which may include (see
         <a class="local">
          'Complications'
         </a>
         above):
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased mortality risk – Neonatal mortality appears to be increased only in LGA term infants with BWs &gt;5000 g compared with AGA term infants. (See
         <a class="local">
          'Mortality'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Perinatal asphyxia and low five-minute Apgar scores. (See
         <a class="local">
          'Perinatal asphyxia'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Birth injuries (eg, brachial plexus injury, perinatal asphyxia, and clavicular injury) primarily due to shoulder dystocia. (See
         <a class="local">
          'Birth injury'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5031.html" rel="external">
          "Neonatal birth injuries"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5397.html" rel="external">
          "Shoulder dystocia: Intrapartum diagnosis, management, and outcome"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Respiratory distress, which may be due to transient tachypnea of the newborn, meconium aspiration, or respiratory distress syndrome. (See
         <a class="local">
          'Respiratory distress'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/4964.html" rel="external">
          "Overview of neonatal respiratory distress and disorders of transition"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hypoglycemia. (See
         <a class="local">
          'Hypoglycemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Polycythemia. (See
         <a class="local">
          'Polycythemia'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Congenital abnormalities such as talipes calcaneovalgus, hip subluxation, and hydrocephalus. (See
         <a class="local">
          'Congenital anomalies'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Hospital readmission after discharge from the birth hospitalization. (See
         <a class="local">
          'Hospital readmissions'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent2">
         <span class="glyph">
          •
         </span>
         Increased risk of obesity, insulin resistance, and cardiovascular disease in adulthood. (See
         <a class="local">
          'Potential long-term effects'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Evaluation and management of LGA newborns –
         </strong>
         Management of LGA newborns includes assessing for and treating complications associated with macrosomia (eg, hypoglycemia, respiratory distress); evaluating for the underlying etiology of increased growth, if not readily apparent from the history and physical examination; and providing routine newborn care. (See
         <a class="local">
          'Evaluation and management of the LGA newborn'
         </a>
         above and
         <a class="medical medical_review" href="/z/d/html/5068.html" rel="external">
          "Overview of the routine management of the healthy newborn infant"
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         All LGA infants should undergo screening for hypoglycemia within the first hours following birth, as described separately. (See
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia", section on 'Screening'
         </a>
         .)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         If the newborn has any signs or symptoms that may be due to polycythemia (eg, cyanosis, tachypnea, poor feeding), the hematocrit should be measured. (See
         <a class="medical medical_review" href="/z/d/html/5940.html" rel="external">
          "Neonatal polycythemia", section on 'Diagnosis'
         </a>
         .)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Xu H, Simonet F, Luo ZC. Optimal birth weight percentile cut-offs in defining small- or large-for-gestational-age. Acta Paediatr 2010; 99:550.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boulet SL, Alexander GR, Salihu HM, Pass M. Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk. Am J Obstet Gynecol 2003; 188:1372.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Aris IM, Kleinman KP, Belfort MB, et al. A 2017 US Reference for Singleton Birth Weight Percentiles Using Obstetric Estimates of Gestation. Pediatrics 2019; 144.
          </a>
         </li>
         <li class="breakAll">
          National Vital Statistics Reports; Births: Final Data for 2021; Volume 72, Number 1, January 31, 2023. Available at: https://www.cdc.gov/nchs/data/nvsr/nvsr72/nvsr72-01.pdf (Accessed on July 24, 2023).
         </li>
         <li>
          <a class="nounderline abstract_t">
           Männik J, Vaas P, Rull K, et al. Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns. J Clin Endocrinol Metab 2010; 95:2433.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Freemark M. Placental hormones and the control of fetal growth. J Clin Endocrinol Metab 2010; 95:2054.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Filiberto AC, Maccani MA, Koestler D, et al. Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta. Epigenetics 2011; 6:566.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Haworth KE, Farrell WE, Emes RD, et al. Methylation of the FGFR2 gene is associated with high birth weight centile in humans. Epigenomics 2014; 6:477.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           DeVader SR, Neeley HL, Myles TD, Leet TL. Evaluation of gestational weight gain guidelines for women with normal prepregnancy body mass index. Obstet Gynecol 2007; 110:745.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Linder N, Lahat Y, Kogan A, et al. Macrosomic newborns of non-diabetic mothers: anthropometric measurements and neonatal complications. Arch Dis Child Fetal Neonatal Ed 2014; 99:F353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Gillean JR, Coonrod DV, Russ R, Bay RC. Big infants in the neonatal intensive care unit. Am J Obstet Gynecol 2005; 192:1948.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lackman F, Capewell V, Richardson B, et al. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards. Am J Obstet Gynecol 2001; 184:946.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Spellacy WN, Miller S, Winegar A, Peterson PQ. Macrosomia--maternal characteristics and infant complications. Obstet Gynecol 1985; 66:158.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ju H, Chadha Y, Donovan T, O'Rourke P. Fetal macrosomia and pregnancy outcomes. Aust N Z J Obstet Gynaecol 2009; 49:504.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Groenendaal F, Elferink-Stinkens PM, Netherlands Perinatal Registry . Hypoglycaemia and seizures in large-for-gestational-age (LGA) full-term neonates. Acta Paediatr 2006; 95:874.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Schaefer-Graf UM, Rossi R, Bührer C, et al. Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers. Am J Obstet Gynecol 2002; 187:913.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Dollberg S, Marom R, Mimouni FB, Yeruchimovich M. Normoblasts in large for gestational age infants. Arch Dis Child Fetal Neonatal Ed 2000; 83:F148.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Lapunzina P, Camelo JS, Rittler M, Castilla EE. Risks of congenital anomalies in large for gestational age infants. J Pediatr 2002; 140:200.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Nimal M, Ravel C, Nauleau S, et al. Relationship between large and small for gestational age and hospital readmission after postpartum discharge: a population-based, data-linkage study. Eur J Pediatr 2023; 182:2245.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Sørensen HT, Sabroe S, Rothman KJ, et al. Relation between weight and length at birth and body mass index in young adulthood: cohort study. BMJ 1997; 315:1137.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Seidman DS, Laor A, Gale R, et al. A longitudinal study of birth weight and being overweight in late adolescence. Am J Dis Child 1991; 145:782.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Chiavaroli V, Giannini C, D'Adamo E, et al. Insulin resistance and oxidative stress in children born small and large for gestational age. Pediatrics 2009; 124:695.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Darendeliler F, Poyrazoglu S, Sancakli O, et al. Adiponectin is an indicator of insulin resistance in non-obese prepubertal children born large for gestational age (LGA) and is affected by birth weight. Clin Endocrinol (Oxf) 2009; 70:710.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Giapros V, Evagelidou E, Challa A, et al. Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight. Clin Endocrinol (Oxf) 2007; 66:353.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Evagelidou EN, Kiortsis DN, Bairaktari ET, et al. Lipid profile, glucose homeostasis, blood pressure, and obesity-anthropometric markers in macrosomic offspring of nondiabetic mothers. Diabetes Care 2006; 29:1197.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mohseni R, Mohammed SH, Safabakhsh M, et al. Birth Weight and Risk of Cardiovascular Disease Incidence in Adulthood: a Dose-Response Meta-analysis. Curr Atheroscler Rep 2020; 22:12.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Rustogi D, Synnes A, Alshaikh B, et al. Neurodevelopmental outcomes of singleton large for gestational age infants &lt;29 weeks' gestation: a retrospective cohort study. J Perinatol 2021; 41:1313.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Paulson JF, Mehta SH, Sokol RJ, Chauhan SP. Large for gestational age and long-term cognitive function. Am J Obstet Gynecol 2014; 210:343.e1.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Mitha A, Chen R, Razaz N, et al. Neurological development in children born moderately or late preterm: national cohort study. BMJ 2024; 384:e075630.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Boghossian NS, Geraci M, Edwards EM, Horbar JD. In-Hospital Outcomes in Large for Gestational Age Infants at 22-29 Weeks of Gestation. J Pediatr 2018; 198:174.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Baer RJ, Rogers EE, Partridge JC, et al. Population-based risks of mortality and preterm morbidity by gestational age and birth weight. J Perinatol 2016; 36:1008.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Ozawa J, Tanaka K, Kabe K, et al. Impact of being large-for-gestational-age on neonatal mortality and morbidities in extremely premature infants. Pediatr Res 2021; 90:910.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 5059 Version 33.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20064130" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Optimal birth weight percentile cut-offs in defining small- or large-for-gestational-age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12748514" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Macrosomic births in the united states: determinants, outcomes, and proposed grades of risk.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31201230" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : A 2017 US Reference for Singleton Birth Weight Percentiles Using Obstetric Estimates of Gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/31201230" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : A 2017 US Reference for Singleton Birth Weight Percentiles Using Obstetric Estimates of Gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20233782" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Differential expression profile of growth hormone/chorionic somatomammotropin genes in placenta of small- and large-for-gestational-age newborns.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/20444932" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Placental hormones and the control of fetal growth.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/21521940" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Birthweight is associated with DNA promoter methylation of the glucocorticoid receptor in human placenta.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/25431941" id="rid7" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          8 : Methylation of the FGFR2 gene is associated with high birth weight centile in humans.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17906004" id="rid8" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          9 : Evaluation of gestational weight gain guidelines for women with normal prepregnancy body mass index.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24792775" id="rid9" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          10 : Macrosomic newborns of non-diabetic mothers: anthropometric measurements and neonatal complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/15970858" id="rid10" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          11 : Big infants in the neonatal intensive care unit.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11303203" id="rid11" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          12 : The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/4022478" id="rid12" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          13 : Macrosomia--maternal characteristics and infant complications.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19780734" id="rid13" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          14 : Fetal macrosomia and pregnancy outcomes.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16801190" id="rid14" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          15 : Hypoglycaemia and seizures in large-for-gestational-age (LGA) full-term neonates.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/12388976" id="rid15" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          16 : Rate and risk factors of hypoglycemia in large-for-gestational-age newborn infants of nondiabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/10952712" id="rid16" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          17 : Normoblasts in large for gestational age infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/11865271" id="rid17" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          18 : Risks of congenital anomalies in large for gestational age infants.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36869901" id="rid18" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          19 : Relationship between large and small for gestational age and hospital readmission after postpartum discharge: a population-based, data-linkage study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/9374888" id="rid19" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          20 : Relation between weight and length at birth and body mass index in young adulthood: cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/2058611" id="rid20" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          21 : A longitudinal study of birth weight and being overweight in late adolescence.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/19651586" id="rid21" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          22 : Insulin resistance and oxidative stress in children born small and large for gestational age.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/18759869" id="rid22" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          23 : Adiponectin is an indicator of insulin resistance in non-obese prepubertal children born large for gestational age (LGA) and is affected by birth weight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/17302868" id="rid23" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          24 : Serum adiponectin and leptin levels and insulin resistance in children born large for gestational age are affected by the degree of overweight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/16731995" id="rid24" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          25 : Lipid profile, glucose homeostasis, blood pressure, and obesity-anthropometric markers in macrosomic offspring of nondiabetic mothers.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/32328820" id="rid25" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          26 : Birth Weight and Risk of Cardiovascular Disease Incidence in Adulthood: a Dose-Response Meta-analysis.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/34035448" id="rid26" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          27 : Neurodevelopmental outcomes of singleton large for gestational age infants&lt;29 weeks' gestation: a retrospective cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24211483" id="rid27" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          28 : Large for gestational age and long-term cognitive function.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/38267070" id="rid28" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          29 : Neurological development in children born moderately or late preterm: national cohort study.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/29631772" id="rid29" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          30 : In-Hospital Outcomes in Large for Gestational Age Infants at 22-29 Weeks of Gestation.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/27467566" id="rid30" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          31 : Population-based risks of mortality and preterm morbidity by gestational age and birth weight.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/33504968" id="rid31" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          32 : Impact of being large-for-gestational-age on neonatal mortality and morbidities in extremely premature infants.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
